Hypotonia and Polyp

Summary:

Polyp is reported only by a few people with Hypotonia.

The study analyzes which people have Polyp with Hypotonia. It is created by eHealthMe based on 2 people who have Polyp and Hypotonia from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

2 people who have Hypotonia and Polyp are studied.

What is Hypotonia?

Hypotonia (low muscle tone) is found to be associated with 2,163 drugs and 1,664 conditions by eHealthMe.

What is Polyp?

Polyp is found to be associated with 1,393 drugs and 757 conditions by eHealthMe.

Number of Polyp in Hypotonia reports submitted per year:

Would you have Polyp when you have Hypotonia?

Gender of people who have Hypotonia and experienced Polyp *:

female: 100 %
male: 0.0 %

Age of people who have Hypotonia and experienced Polyp *:

Common co-existing conditions for these people *:

Weight Loss: 2 people, 100.00%
Pain: 2 people, 100.00%

Common symptoms for these people *:

Choledocholithiasis (stones in the common bile duct): 2 people, 100.00%
Acquired Porphyria (group of disorders that result in a build up of chemicals called porphyrins in the body): 2 people, 100.00%
Hypophagia (reduced food intake): 1 person, 50.00%
Gastrointestinal Hypomotility (less activity of the intestinal tract): 1 person, 50.00%
Colonic Polyp (extra part of colon tissue grow in intestine): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Polyp?

Check whether Polyp is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Hypotonia (13,508 reports)
Polyp (8,053 reports)

COVID vaccines that are related to Polyp:

Common drugs associated with Polyp:

All the drugs that are associated with Polyp:

Polyp (1,393 drugs)

Common conditions associated with Polyp:

High blood pressure: 970 reports
Rheumatoid arthritis: 664 reports
Crohn's disease: 407 reports
Asthma: 358 reports
Gastroesophageal reflux disease: 330 reports

All the conditions that are associated with Polyp:

Polyp (757 conditions)

How the study uses the data?

The study is based on Polyp and Hypotonia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.